Validation of the GSP(®)/DELFIA(®) Anti-SARS-CoV-2 IgG Kit Using Dried Blood Samples for High-Throughput Serosurveillance and Standardized Quantitative Measurement of Anti-Spike S1 IgG Antibody Responses Post-Vaccination

Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has caused a major global public health crisis. In response, researchers and pharmaceutical companies worked together for the rapid development of vaccines to reduce the morbidity and mortality associated with viral infection. Monitoring h...

Descripción completa

Detalles Bibliográficos
Autores principales: Cicalini, Ilaria, Del Boccio, Piero, Zucchelli, Mirco, Rossi, Claudia, Natale, Luca, Demattia, Gianmaria, De Bellis, Domenico, Damiani, Verena, Tommolini, Maria Lucia, Pizzinato, Erika, Frisco, Alberto, Verrocchio, Sara, Bucci, Ines, Stuppia, Liborio, De Laurenzi, Vincenzo, Pieragostino, Damiana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9028589/
https://www.ncbi.nlm.nih.gov/pubmed/35455263
http://dx.doi.org/10.3390/vaccines10040514

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9028589/
https://www.ncbi.nlm.nih.gov/pubmed/35455263
http://dx.doi.org/10.3390/vaccines10040514

Ejemplares similares